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ABBREVIATIONS
FOXG1 Forkhead Box G1
AIM Forkhead Box G1 (FOXG1) syndrome is a developmental encephalopathy characterized
by postnatal microcephaly, structural brain abnormalities, facial dysmorphisms, severe delay
with absent language, defective social interactions, and epilepsy. Abnormal movements in
FOXG1 syndrome have often been mentioned but not characterized.
METHOD We clinically assessed and analysed video recordings of eight patients with
different mutations or copy number variations affecting the FOXG1 gene and describe the
peculiar pattern of the associated movement disorder.
RESULTS The age of the patients in the study ranged from 2 to 17 years old (six females, two
males). They had severe epilepsy and exhibited a complex motor disorder including various
combinations of dyskinetic and hyperkinetic movements featuring dystonia, chorea, and
athetosis. The onset of the movement disorder was apparent within the first year of life,
reached its maximum expression within months, and then remained stable.
INTERPRETATION A hyperkinetic–dyskinetic movement disorder emerges as a distinctive
feature of the FOXG1-related phenotype. FOXG1 syndrome is as an epileptic–dyskinetic
encephalopathy whose clinical presentation bears similarities with ARX- and STXBP1-gene
related encephalopathies.
Forkhead Box G1 (FOXG1), an evolutionarily conserved
winged-helix transcriptional repressor, plays an important role
in telencephalon development1 and is a crucial component of
the transcription regulatory network that controls prolifera-
tion, differentiation, neurogenesis, and neurite outgrowth.2,3
The core phenotype of the FOXG1 syndrome includes
postnatal microcephaly, severe developmental delay with
defective social interactions, and absence of language.
Additional manifestations include behavioural disturbances,
stereotypies, dyskinesia, and epilepsy.4–6 Agenesis of corpus
callosum, simplified gyral pattern, and cortical thickening
of the frontal lobes are commonly observed on brain mag-
netic resonance imaging.4 Characteristic facial dysmor-
phisms, including round face, flat midface and forehead,
epicanthal folds, depressed nasal bridge, upturned nose,
and abnormally formed ears have also been described, most
often in patients with large 14q12 deletions.
Abnormal movements in FOXG1 syndrome have been
frequently mentioned,4,7,8 but a systematic description is
lacking. We describe eight patients with different muta-
tions or copy number variations affecting the FOXG1 gene
and characterize the associated peculiar pattern of move-
ment disorder.
CASE REPORT
We obtained clinical data and brain magnetic resonance
imaging findings from eight Italian patients (six females,
two males) with FOXG1-related encephalopathy as diag-
nosed by clinical and genetic criteria. We also assessed all
the patients with repeated video recordings in order to
characterize their abnormal motor pattern. We followed
them up with serial clinical evaluations in order to appreci-
ate the movement disorder progression and any relevant
clinical changes. We obtained blood or DNA samples from
patients and their parents after written informed consent.
Parents gave their consent to publish the results. The study
was approved by the Institutional Review Board of the
Tuscany Region, Italy.
Neurological examination revealed typical clinical and
behavioural features of the FOXG1 syndrome (Table I)
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including postnatal microcephaly (7/8 patients), facial dys-
morphisms (8/8), axial hypotonia (6/8), absence of lan-
guage (8/8), severe developmental delay (8/8), poor sleep
pattern (6/8), hyperactivity (6/8), and crying or inappropri-
ate laughing (5/8) (Table I). Brain magnetic resonance
imaging revealed corpus callosum dysgenesis (6/8 patients)
and a simplified gyral pattern in some patients (3/8) (Fig. 1).
Most patients exhibited focal seizures (5/8), which had
appeared from age 5 months to 6 years, often in association
with epileptic spasms and requiring multiple antiepileptic
medications. No significant period of remission of seizures
was observed. Electroencephalography showed slow back-
ground, multifocal spikes, and sharp waves. Five patients
exhibited a severe movement disorder (Patients 1, 2, 3, 5,
and 7), manifested as continuous dyskinesia with a mixture
of hyperkinetic, dystonic, choreic, and athetoid movements
mainly involving the four limbs and face, and stereotypic
movements that largely impaired normal hand use and fine
motor skills. Dyskinesia of the mouth–tongue area was a
prominent feature and was associated with hand-mouthing
and sialorrhoea. There was, however, no evidence of dyspha-
gia or swallowing difficulties. These patients had not
reached independent walking and were overall severely dis-
abled by the movement disorder. Two patients (Patients 6
and 8) exhibited only mild distal dyskinetic movements
involving the arms and were able to walk with support. One
patient (Patient 4), carrying a 14q12 duplication, had a dis-
tinctively less severe phenotype featuring mild hyperkinetic
and perseverative stereotyped hand–mouth movements.
Abnormal movements disappeared during sleep. The abnor-
mal movements were first noticed between the fifth and
twelfth month of life and had not changed in severity and
semiology at last follow-up, between age 2 years and
17 years, as documented by video recordings (see Videos
S1–S4, online supporting information).
Three patients were treated with antidyskinetic drugs
(Patients 1, 5, and 7) (Table I). Limited benefit was
obtained using pimozide in two patients (Patients 1 and 7).
Genetic analysis through multiplex ligation-dependent
probe amplification (SALSA P075 version A1, MRC-Hol-
land, Amsterdam, the Netherlands) revealed two de novo
deletions of the FOXG1 gene in Patients 1 and 3. Array
comparative genomic hybridization confirmed a 2.5Mb
deletion in Patient 1 (between nucleotides 27 154 000 and
29 743 000) and a 9.1Mb deletion in Patient 3. This is the
largest deletion reported so far at chromosome 14q12 (be-
tween nucleotides 25 168 212 and 34 247 857), which
includes the FOXG1 and flanking genes. In Patient 2, array
comparative genomic hybridization revealed a de novo
14q12 deletion of 2.8Mb (minimal deleted interval
27 265 913–30 511 768). In Patient 4, multiplex ligation-
dependent probe amplification identified a de novo dupli-
cation involving FOXG1, which was confirmed by array
comparative genomic hybridization to be 7.3Mb in length
(minimal deleted interval 24 453 489–31 784 795)
(Table I). Array comparative genomic hybridization was
performed using the whole genome 180K Agilent platform
(Agilent Technologies, Santa Clara, CA, USA). Physical
positions correspond to the UCSC genome browser (gen-
ome assembly Feb 2009, hg19, http://genome.ucsc.edu).
Sanger sequencing detected four heterozygous FOXG1
intragenic point mutations, including a novel frameshift
mutation c.298delC (p.Gln100Serfs*92) in Patient 5, a
nonsense mutation c.136C>T (p.Q46X) in Patient 6, a
recurrent frameshift mutation c.460dupG (p.Glu154G-
lyfs*301) in patient 7, and a frameshift mutation c.256delC
(p.Gln86Argfs*106) in Patient 8 (FOXG1 Genbank Acces-
sion Number NM_005249).
All four point mutations were de novo and caused loss
of all three downstream functional critical domains of the
gene: the forkhead domain (FHD), which allows the bind-
ing to DNA, and the Groucho binding domain (GBD) and
the JARID1B binding domain (JBD), which recruit tran-
scriptional corepressor proteins. All mutations are pre-
dicted to cause haploinsufficiency.
DISCUSSION
Eighty-eight mutations involving the FOXG1 gene have
been described in more than 90 patients and include 36
intragenic sequence changes (missense, nonsense, and fra-
meshift), 27 deletions, 17 duplications, and 8 complex rear-
rangements.9
Despite the relatively large number of identified muta-
tions and reported patients, genotype–phenotype correla-
tions are emerging slowly. Initial descriptions had
ostensibly labelled FOXG1-related phenotypes as a ‘con-
genital variant’ of Rett syndrome.10 Only the subsequent
identification of additional patients with FOXG1 muta-
tions, having different ages and exhibiting sufficiently dis-
tinctive clinical features, suggested the ‘FOXG1 syndrome’
to be a specific ‘developmental encephalopathy’.4 As is
often the case with newly identified clinical entities, after
the core phenotypic features have initially been character-
ized and a causative gene found, collection of a larger
number of observations, including less typical cases, allows
a proper characterization of the whole clinical spectrum.5
In our series, all the patients exhibited the common clin-
ical symptoms previously associated with FOXG1 syn-
drome.4,6,8 Almost all patients also exhibited a prominent
movement disorder of variable severity. Five patients (1, 2,
3, 5, and 7) harbouring deletions or mutations exhibited a
complex and more severe movement disorder initially
noticed within first year of life and featuring hyperkinetic,
dystonic, choreic, and athetoid movements, mainly involv-
ing the orobuccal area and extremities, with upper limb
predominance severely interfering with voluntary move-
ment (Video S1–S4). Two patients with truncating muta-
tions exhibited only distal dyskinetic movements of the
upper extremities (Patients 6 and 8), which in this series
What this paper adds
• Assessment of movement disorder in patients with FOXG1 mutations or copy
number variations.
• FOXG1 syndrome can be defined as an epileptic–dyskinetic encephalopathy.
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represents the mild end of the movement disorder spec-
trum. No significant worsening or attenuation of the
abnormal movements was apparent in any of the patients
over time.
Assessment of our patients and the review of previous
reports in which the movement disorder was mentioned,
suggest its presence in most cases, with a variable combina-
tion of dyskinetic and hyperkinetic movements and, with
few exceptions,7 an age at onset within the first years of
life.
We could not find a genotype–phenotype correlation
between the type of genetic defect affecting FOXG1 and
the severity of the movement disorder since all the truncat-
ing mutations and deletions we observed (Patients 1–3, 5–
8) were predicted to cause haploinsufficiency. The duplica-Ta
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Figure 1: Representative brain magnetic resonance imaging showing the
main anatomic abnormalities in two patients in comparison to a normal
brain. (a), (c), and (e) sagittal sections passing through the midline and
showing the corpus callosum and midline strictures. (b), (d), and (f) axial
sections passing through the Sylvian fissures and the lateral ventricles.
(a) and (e) T1-weighted images; (b), (c), (d), and (f) T2-weighted images.
(c) and (e) demonstrate corpus callosum hypoplasia (arrows). (d) and (f)
show a simplified gyral pattern in the frontal lobes (arrows) which also
appear considerably reduced in volume. (f) there is also marked enlarge-
ment of the lateral ventricles (asterisk), with the basal ganglia and tha-
lami protruding into the ventricular lumen.
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tion at 14q12 in Patient 4 was associated with hand–mouth
stereotypies and less prominent hyperkinetic movements.
Clinical features in patients with 14q12 duplications have
been consistently reported to differ from those observed in
association with deletions and inactivating mutations, sug-
gesting that the phenotype is markedly influenced by
FOXG1 gene dosage.
Overall, the severe movement disorder observed in most
patients in this series is also remarkably different from that
described in Rett syndrome, in which hyperkinetic
choreoathetoid movements are unusual and not as promi-
nent.11
Unfortunately, no effective antidyskinetic treatment for
these patients has been reported to date and our experience
does not allow us to draw any conclusion with respect to
treatment issues. However, we noticed that among the
three patients who performed antidyskinetic therapy
(Table I), the two who were treated with pimozide, exhib-
ited some improvement (Patients 1 and 7). This prelimi-
nary observation might encourage further therapeutic trials
against the hyperkinetic–dyskinetic movements. We did
not observe any (beneficial or worsening) effect of the dif-
ferent antiepileptic medications on the movement disorder
either.
The FOXG1-related phenotype can be classified as an
epileptic–dyskinetic encephalopathy as are ARX-12–14 and
STXBP1-related15 encephalopathies. We recommend the
consideration of FOXG1 mutational analysis in the diag-
nostic assessment of patients with developmental delay,
epilepsy, and prominent dyskinetic movements.
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SUPPORTING INFORMATION
The following additional material may be found online:
Video S1: Patient 1: Severe hyperkinetic–dyskinetic movement
disorder affecting all four limbs, with prominent hand–mouth–
tongue movements. This patient is severely affected, has a very
poor control of her posture, and is non-ambulatory.
Video S2: Patient 5: Hyperkinetic–dyskinetic movements
affecting the upper limbs. Finalized hand movements are
impaired. This patient is severely affected, has a very poor control
of her posture, and is non-ambulatory.
Video S3: Patient 7: Severe generalized hyperkinetic–dyskinetic
movement disorder affecting the four limbs and the face, mark-
edly impairing fine motor skills. The male’s motor development
is severely delayed.
Video S4: Patient 8: Mild dyskinetic movements involving the
upper extremities. There are no dyskinetic movements in the
lower extremities. This female is able to walk with support.
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